Patrys Limited (ASX:PAB)
Australia · Delayed Price · Currency is AUD 0.0290
-0.0010 (-3.33%)
At close: Mar 27, 2026
Patrys Market Cap
Patrys has a market cap or net worth of 15.53 million as of March 27, 2026. Its market cap has increased by 151.63% in one year.
Market Cap
15.53M
Enterprise Value
13.62M
Revenue
100.38K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 15.53M, a decrease of -84.00%. That is a compound annual growth rate of -9.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 15.53M | 62.74% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Algorae Pharmaceuticals | 29.19M |
| NeuroScientific Biopharmaceuticals | 23.61M |
| Argenica Therapeutics | 21.84M |
| Noxopharm | 18.13M |
| Neurotech International | 16.85M |
| Immuron | 10.78M |
| AdAlta | 10.20M |
| Bio-Gene Technology | 9.76M |